Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors
about
Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcriptionRoscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factorsPrimitive hematopoietic cells resist HIV-1 infection via p21Therapeutic targets for HIV-1 infection in the host proteome.Use of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysisTargeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitorsProtein profile of tax-associated complexesAntiviral activity of CYC202 in HIV-1-infected cellsCD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21Molecular dynamics simulation and experimental verification of the interaction between cyclin T1 and HIV-1 Tat proteinsEpizootic hemorrhagic disease virus induces and benefits from cell stress, autophagy, and apoptosis.Identifying the membrane proteome of HIV-1 latently infected cells.Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenanceA cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4(+) T cells from elite controllersAccumulation of substrates of the anaphase-promoting complex (APC) during human cytomegalovirus infection is associated with the phosphorylation of Cdh1 and the dissociation and relocalization of APC subunits.Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope.A flavonoid, luteolin, cripples HIV-1 by abrogation of tat function.The cyclin-dependent kinase inhibitor SCH 727965 (dinacliclib) induces the apoptosis of osteosarcoma cellsHuman cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7.The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0.Apoptosis of osteosarcoma cultures by the combination of the cyclin-dependent kinase inhibitor SCH727965 and a heat shock protein 90 inhibitor.Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteinsIdentification of homeodomain proteins, PBX1 and PREP1, involved in the transcription of murine leukemia virus.Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction.Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replicationInduction of G1 cycle arrest in T lymphocytes results in increased extracellular levels of beta-chemokines: a strategy to inhibit R5 HIV-1.Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy.Inhibition of HIV-1 Tat-mediated transcription by a coumarin derivative, BPRHIV001, through the Akt pathway.Select host restriction factors are associated with HIV persistence during antiretroviral therapy.Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complexGalectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infectionUse of ATP analogs to inhibit HIV-1 transcription.Cdk inhibitory nucleoside analogs prevent transcription from viral genomes.Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs.Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction.Cyclin-dependent kinase 5 (Cdk5) regulates the function of CLOCK protein by direct phosphorylation.Cyclin-dependent kinase activity is required at early times for accurate processing and accumulation of the human cytomegalovirus UL122-123 and UL37 immediate-early transcripts and at later times for virus production.Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes.Phosphorylation site mutations affect herpes simplex virus type 1 ICP0 function.
P2860
Q24559797-B5725008-EB23-4073-9B3B-A88A4F745776Q24562983-D2884DA1-5DEC-453C-A042-CB73DB0F58ACQ24681819-48535EAF-0A3E-4E6F-BDAD-FC1374EBC107Q24795470-0330905A-3F25-4B26-92ED-B79CBA572F2FQ24799552-60C9E07A-4355-4DDE-A74B-A9389F1D45E4Q26827580-EAAE58FC-62E8-46F5-BDA1-B8839AB81155Q28207756-B54334CA-4814-43A9-852A-447D27A458F5Q28292152-040B65E4-F3C9-4E47-9CC1-27F5687D033DQ28307312-5D8B2093-C1B7-447D-8C9D-6377A94EB30EQ28544421-AD04514C-CE76-489F-AC1E-0405B30FD679Q30557606-AEB02470-47A3-4BBA-8591-E4D2CC781B5FQ33269741-D321D047-26D8-4212-8A4E-734CFFF64B16Q33786506-447B7BE9-E42D-477A-AE67-2AF158E2C78EQ33811660-23F434FF-7DB4-45D6-A06A-CAC45FD575E8Q34007645-189FED05-9BB7-4AC1-BE53-4E900D36955DQ34019744-43C97433-7EB6-4043-B4FB-276F21216AEEQ34090039-55F54F79-BAA7-4DB9-BEEB-7A3EA179B48DQ34091121-463BE2FB-FE50-4541-B998-3F86008DA021Q34178106-4C7EF58B-0ACB-4C1F-830F-9887D2D0B3B0Q34228694-E6F75972-BE8A-4BBA-A3B5-7FC45402E9EAQ34330457-810F1CD9-1977-483D-8CA7-C558B2658169Q34335802-A29CCB78-5D5F-4352-AA5C-FF9EA43F8ACDQ34343774-3A22C955-FCF7-4AE6-B93B-896D5256E78BQ34463374-764CE197-7F61-495C-BB51-5B5873BA4C04Q34527341-63B982DC-DE9C-49DA-9E59-01AD47D513BBQ34553293-86537DEF-F792-4E50-A797-D93DB79350A5Q34922802-D07C4407-0CD7-4F92-BBF7-BA3FC28D3833Q35106892-7ADD08FE-8F2E-42D0-A1F3-4ACE68E63CCBQ35192970-3642873C-FB8A-41DE-8CEB-75DA9074472CQ35271996-0B1321DE-1EC7-4646-B9F6-89B8F744E074Q35940053-FD267720-F7D7-40E0-8A0E-77759E07E05AQ35986628-B3BFE088-A294-4F61-A125-3F1747C3A4B2Q36202709-A36E32F1-576F-47AB-B5DC-2601BB9F0463Q36296415-DECC4F6E-B64D-4FD8-84FA-401950FED317Q36716750-D692CDB7-90D1-44C3-AB41-2EFEBC4C9F5AQ37397177-79D2C733-E060-4A78-94AF-AC14071ECF7DQ37415588-C0AAC622-DB0A-43B1-9310-9C6DC3760337Q37567845-A1A8F9B6-3CAB-4302-9FD2-CA2F0F12F45BQ37647055-DE7FC427-5A71-4B10-8B24-91679DA2D62CQ37743081-9C25B42F-66AE-4DBD-B4CC-C82CB71E8102
P2860
Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inhibition of human immunodefi ...... in-dependent kinase inhibitors
@ast
Inhibition of human immunodefi ...... in-dependent kinase inhibitors
@en
Inhibition of human immunodefi ...... in-dependent kinase inhibitors
@nl
type
label
Inhibition of human immunodefi ...... in-dependent kinase inhibitors
@ast
Inhibition of human immunodefi ...... in-dependent kinase inhibitors
@en
Inhibition of human immunodefi ...... in-dependent kinase inhibitors
@nl
prefLabel
Inhibition of human immunodefi ...... in-dependent kinase inhibitors
@ast
Inhibition of human immunodefi ...... in-dependent kinase inhibitors
@en
Inhibition of human immunodefi ...... in-dependent kinase inhibitors
@nl
P2093
P2860
P3181
P1433
P1476
Inhibition of human immunodefi ...... in-dependent kinase inhibitors
@en
P2093
C de la Fuente
F Kashanchi
I Zilberman
L E Harrison
P2860
P304
P3181
P356
10.1128/JVI.75.16.7266-7279.2001
P407
P50
P577
2001-08-01T00:00:00Z